GOODMAN JESSE — SEC Form 4 filings
SEC reporting owner CIK 1756929. 7 Form 4 filings on record with FilingPulse; latest filed 2026-06-10.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-14 to 2026-06-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 3,094 shares, $29,068 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 1,547 shares @ $9.56 ($14,789) in Intellia Therapeutics, Inc., filed 2025-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. (NTLA) | Director | 4 | — | 2 legs · 3,094 sh · $29,068 | 6 |
| BiomX Inc. (PHGE) | Director | 3 | — | — | 3 |
Form 4 filings — GOODMAN JESSE
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-10 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 9,200 @ $0 · Grant/award (A): 13,300 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | Intellia Therapeutics, Inc. (NTLA) | Sale (S): 1,547 @ $9.56 · Sale (S): 1,547 @ $9.23 | EDGAR |
| 2025-06-13 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 8,000 @ $0 · Grant/award (A): 11,450 (derivative) @ $0 | EDGAR |
| 2025-04-21 | 4/A | BiomX Inc. (PHGE) | Grant/award (A): 17,600 (derivative) @ $0 | EDGAR |
| 2025-04-18 | 4 | BiomX Inc. (PHGE) | Grant/award (A): 17,600 (derivative) @ $0 | EDGAR |
| 2024-07-15 | 4 | BiomX Inc. (PHGE) | Grant/award (A): 264,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Intellia Therapeutics, Inc. (NTLA) | Grant/award (A): 7,737 @ $0 · Grant/award (A): 11,515 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1756929 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →